The US has approved the first pill for postpartum depression. The Food and Drug Administration (FDA) said zuranolone, sold under the brand name Zurzuvae, has been approved as a once-daily pill taken for two weeks. Until now, treatment for postpartum depression (PPD) was available only as an intravenous injection, the FDA said. Drug manufacturers Sage […]